Alternaturals, Inc. (OTCPK: ANAS)
Health Care · Pharmaceuticals · US
$0.02
-7.64% today · +100.0% 1Y
Alternaturals, Inc. (OTCPK: ANAS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.56M and employs 2 people.
Over the last twelve months the share price has gained 100.0%, trading between 0.01 and 0.02.
ANAS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.56M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -5.86
- 52-week high
- $0.02
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 104.25M
- Employees
- 2
- Next earnings
- —
About Alternaturals, Inc.
Alternaturals, Inc. operates as an innovative agricultural technology firm. The company has pioneered a highly efficient and environmentally pristine approach to extensive cultivation, thereby delivering the freshest and safest produce to its clientele. The core of their operations lies in advanced plant factories, which leverage a sophisticated blend of sensing components, Information and Communication Technology (ICT), the Internet of Things (IoT), and big data. These are complemented by specialized agricultural ERP systems and draw power from sustainable green energy sources, including wind and solar. Ultimately, their overarching goal is to furnish sustainable and eco-conscious agricultural solutions.
- ISIN
- US02154R2094
- Founded
- 1995
- Listed since
- Jul 7, 1998
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.